Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial

Harvey White^*, H. D. White, R. J. Simes, P. E G Aylward, P. W. Armstrong, R. M. Califf, J. K. French, C. B. Granger, I. C. Marschner, E. J. Topol, F. J. Van De Werf, R. G. Wilcox

^*Corresponding author for this work